Condition · Neurology
Ischemic Stroke Recovery
00
Background biology
Stroke recovery involves reperfusion, inflammation, neuronal survival, plasticity and intensive rehabilitation.
01
Evidence-ranked peptides
| Peptide | Use | Evidence |
|---|---|---|
| Semax Semax is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Ischemic Stroke Recovery insufficient | Human3/5 Animal2/5 Safety3/5 3 verified refs |
| Cerebrolysin Cerebrolysin is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Ischemic Stroke Recovery weak | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| CN-105 CN-105 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Ischemic Stroke Recovery insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
02
Current standard management
conventional medicineEmergency reperfusion treatment when eligible, stroke-unit care, secondary prevention and multidisciplinary rehabilitation are standard care.
Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.
04
Linked mechanisms
biological pathways discussed for this condition- Melanocortin and neurotrophic signallinglimited
- Neuroplasticitylimited
05
Research gaps
what we don't know yet- ·Independent Semax trials
- ·Modern multicentre randomized evidence
- ·Long-term functional outcomes
- ·Generalizability beyond regional studies
03
Community observations
No approved community reports for this condition yet. Submit one.
Clinician discussion
Questions you can ask a qualified clinician
- What are the established evidence-based options for this condition?
- What monitoring is appropriate before considering any experimental intervention?
- What long-term safety data exists for peptide-based approaches?
- Are there licensed medicines relevant to my situation?
↳
Explore further
from the knowledge graphPeptides that touch this
Mechanisms in play